Get Live Data

Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
GreenRoc Accelerates their World Class Project to Production as Early as 2028
GreenRoc Accelerates their World Class Project to Production as Early as 2028View Video

Latest Share Chat

  2. Share Prices
  3. ORPH.L Share Price
  4. ORPH.L Share News
  5. IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive

Pin to quick picksORPH.L Share News (ORPH)

ORPH.L Information
  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive

Thu, 24th Feb 2022 14:48

Open Orphan PLC - London-based pharmaceutical services - Moves Non-Executive Director Mo Khan to chief executive officer, effective immediately. Khan had joined the Open Orphan board back in October. The company notes he has 25 years of clinical research experience. Cathal Friel remains executive chair, while Open Orphan will aim to find a new independent non-executive director within the next six months.

Current stock price: 13.53 pence, down 9.8% on Thursday

12-month change: down 50%

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Nov 2019 16:29

Open Orphan inks preferred partner deal with Ipsen Group

(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform Open Orphan announced the signing of a preferred partner agreement with Ipsen Group on Monday.

Read more
11 Nov 2019 13:48

Open Orphan Inks Venn Life Preferred Partner Agreement With Ipsen

Open Orphan Inks Venn Life Preferred Partner Agreement With Ipsen

Read more
15 Oct 2019 13:11

Open Orphan Inks Health Data Platform Deal With Empiric Logic

Open Orphan Inks Health Data Platform Deal With Empiric Logic

Read more
15 Oct 2019 11:13

Open Orphan signs deal with Empiric Logic to complete Health Data platform

(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform provider Open Orphan has signed a new strategic collaboration agreement with Empiric Logic, it announced on Tuesday, to build on the earlier work it had performed, and complete the build out of its 'Health Data' platform as Europe's first rare disease, advocacy-led genomic database.

Read more
25 Sep 2019 11:51

Open Orphan Loss Widens On Venn Life Sciences Combination Cost

Open Orphan Loss Widens On Venn Life Sciences Combination Cost

Read more
1 Aug 2019 17:37

Open Orphan Names Ex-Horizon Therapeutics Director As Non-Executive

(Alliance News) - Drug consulting platform Open Orphan PLC said on Thursday that it has appointed David Kelly as an independent non-executive director.Kelly, the company said, has orphan in

Read more
12 Jul 2019 11:57

Open Orphan Divests Remaining 3.1% Stake In Integumen

(Alliance News) - Open Orphan PLC has netted over GBP500,000 after selling the rest of its shares in skin-care firm Integumen PLC, Open Orphan said on Friday.The sale of the 30.1 million on

Read more
234567891011

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.